Serum IL-23 levels in patients with vitiligo
AuthorERDEM, Ummu Gul Bahar
Cengiz, FATMA PELİN
CEMIL, Bengu Cevirgen
MetadataShow full item record
Background and Design: Interleukin-23 (IL-23) is a cytokine which is believed to have an important role in the pathogenesis of autoimmune diseases. Therefore, it can be used as a target molecule in the treatment of autoimmune diseases. The aim of our study was to determine serum IL-23 levels in patients with vitiligo to understand their possible roles in the disease etiology and to compare the results with the healthy controls.